4305

Automatic Segmentation of Liver Tumors for Follow-up CT Scans

Joskowicz Leo, HUJI, School of Computer Science and Engineering, CS

 

Simplifies evaluation of treatment progress

 

Categories

Oncology/Cancer, Medical Applications

Development Stage

Proof of concept completed; ongoing research with larger data sets

Patent Status

Provisional patent application submitted

Highlights

  • Radiological follow-up to assess changes in size of tumors is essential during liver tumor therapy.
  • Volumetric measurements provide the most accurate information about tumor size, but tumor delineation presents a bottleneck in tumor volume computation.
  • Manual delineation is time-consuming, is user-dependent, and requires expert knowledge.
  • Automatic tumor segmentation poses significant challenges and generally processes each scan independently without taking advantage of previous scans of the same patient.

Our Innovation

New automatic algorithm for liver tumor segmentation in follow-up CT scans based on comparison with tumor delineation in a baseline scan using a Convolutional Neural Network learning technique

 4305_-_image.jpg 

Illustration of the main steps of the segmentation process on two tumors (top and bottom row): (a) baseline; (b) tumor with delineation (red) on which the CNN is trained; (c) follow-up tumor with transformed baseline delineation superimposed on it. The deformable registration between the baseline and the follow-up scans is used to set the ROI that contains the follow-up tumor; (d) tumor voxel classification based on the CNN; (e) liver mask for the removal of false positives, and; (f) final segmentation after segmentation leaks removal.

Key Features

  • Enables the segmentation of a large variety of tumor types and sizes.
  • Registration between the baseline and the follow-up scan obviates the need for a separate detection step, significantly increasing robustness and accuracy.
  • Experimental results have shown a 95.4% success rate and an average overlap error of 16.8%, an improvement of 60.3% compared with standalone automatic tumor segmentation results.

Development Milestones

  • The software prototype has been completed and is being tested on a more extensive database of cases.
  • The methodology is being extended to incorporate Deep Learning methods based on Convolutional Neural Networks (CNN).
  • The next step is to install the prototype in a research hospital and integrate it in a study to collect efficacy data and time savings.

The Opportunity

  • Method may be applied to tumors in other organs and to additional imaging modalities, such as MRI
  • According to research firm MarketsandMarkets, the global market for medical image analysis software is expected to reach $3.14 billion by 2020.

 

Contact for more information:

Aviv Shoher
SVP BUSINESS DEVELOPMENT
+972-2-6586635
Contact ME:
Image CAPTCHA